Structural gray matter alterations in glioblastoma and high-grade glioma-A potential biomarker of survival.

Saved in:
Bibliographic Details
Title: Structural gray matter alterations in glioblastoma and high-grade glioma-A potential biomarker of survival.
Authors: Lamichhane B; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Luckett PH; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Dierker D; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA., Yun Park K; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Burton H; Department of Neuroscience, Washington University School of Medicine, St. Louis, Missouri, USA., Olufawo M; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Trevino G; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Lee JJ; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA., Daniel AGS; Department of Biomedical Engineering, Washington University in Saint Louis, St. Louis, Missouri, USA., Hacker CD; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Marcus DS; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA., Shimony JS; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA., Leuthardt EC; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Neuroscience, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Biomedical Engineering, Washington University in Saint Louis, St. Louis, Missouri, USA.; Department of Mechanical Engineering and Materials Science, Washington University, St. Louis, Missouri, USA.; Center for Innovation in Neuroscience and Technology, Washington University School of Medicine, St. Louis, Missouri, USA.; Brain Laser Center, Washington University School of Medicine, St. Louis, Missouri, USA.; Division of Neurotechnology, Washington University School of Medicine, St. Louis, Missouri, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2023 Apr 14; Vol. 5 (1), pp. vdad034. Date of Electronic Publication: 2023 Apr 14 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2632-2498
DOI:10.1093/noajnl/vdad034